Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects.
Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology.
The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the omicsnaming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
The complexity of sugars: regarding their structures, they are not linear instead they are highly branched. Moreover, glycans can be modified (modified sugars), this increases its complexity.

The global Glycomics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Glycomics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Glycomics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Glycomics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Glycomics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
New England Biolabs
ProZyme
Shimadzu Corporation
Merck KGaA
Takara Bio
Thermo Fisher Scientific
Waters Corporation
Agilent Technologies
Bruker Corporation
Danaher Corporation

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Reagents
Instruments
Kits
Enzymes

Segment by Application
Diagnostics
Drug Discovery & Development
Oncology
Immunology
Others